Global Peptide Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.

In this report, we study the peptide-based drugs.

Scope of the Report:
In the last several years, global market of Peptide Therapeutics developed rapidly, with an average growth rate of 7.7%. The major factors that are driving the growth of this market are the rising prevalence of metabolic disorders and the increasing pool of cancer patients. The technological advancements, resulting in a significant reduction in the production cost of peptide drugs, is also boosting this market remarkably. In 2017, global revenue of Peptide Therapeutics is nearly 28.5 billion USD; the actual production is about 150 million units.
The classification of Peptide Therapeutics includes Injection, Oral and other, and the proportion of Injection in 2017 is about 74.2%, and the proportion is decreasing trend from 2013 to 2018.
Peptide Therapeutics is widely sales for Cancer, Metabolic Disorders, Central Nervous System and Others. The key application of peptide therapeutics is into cancer mainly used for treating prostrate, pancreatic, ovarian, and breast cancer. and the consumption proportion is about 33.6% in 2017.
The worldwide market for Peptide Therapeutics is expected to grow at a CAGR of roughly 5.5% over the next five years, will reach 39300 million US$ in 2024, from 28500 million US$ in 2019, according to a new study.
This report focuses on the Peptide Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
Shire
AbbVie
Ipsen
Allergan
Ferring
Merck
The Medicines
Roche
J & J

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Injection
Oral
Other

Market Segment by Applications, can be divided into
Cancer
Metabolic Disorders
Central Nervous System
Other

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Peptide Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Peptide Therapeutics, with price, sales, revenue and global market share of Peptide Therapeutics in 2017 and 2018.
Chapter 3, the Peptide Therapeutics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Peptide Therapeutics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Peptide Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Peptide Therapeutics sales channel, distributors, customers, research findings and conclusion, appendix and data source.